Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index; 49 of the 73 sources its claims cite were checked for support.

Effects of SPI1-mediated transcriptome remodeling on Alzheimer's disease-related phenotypes in mouse models of Aβ amyloidosis

Open access

Abstract

SPI1 was recently reported as a genetic risk factor for Alzheimer's disease (AD) in large-scale genome-wide association studies. However, it is unknown whether SPI1 should be downregulated or increased to have therapeutic benefits. To investigate the effect of modulating SPI1 levels on AD pathogenesis, we performed extensive biochemical, histological, and transcriptomic analyses using both Spi1-knockdown and Spi1-overexpression mouse models. Here, we show that the knockdown of Spi1 expression significantly exacerbates insoluble amyloid-β (Aβ) levels, amyloid plaque deposition, and gliosis. Conversely, overexpression of Spi1 significantly ameliorates these phenotypes and dystrophic neurites. Further mechanistic studies using targeted and single-cell transcriptomics approaches demonstrate that altered Spi1 expression modulates several pathways, such as immune response pathways and complement system. Our data suggest that transcriptional reprogramming by targeting transcription factors, like Spi1, might hold promise as a therapeutic strategy. This approach could potentially expand the current landscape of druggable targets for AD.

Overview

CoChat Summary

## TL;DR

This mouse study tested whether changing Spi1/SPI1 levels alters Alzheimer’s-related amyloid pathology in vivo. Spi1 knockdown worsened Aβ accumulation and gliosis, while Spi1 overexpression reduced amyloid burden, gliosis, and plaque-associated neuritic damage.

## Key findings

  • In 4-month-old APP/PS1 mice, Spi1 knockdown increased insoluble Aβ40 and Aβ42 in cortex by 1.71- and 1.48-fold, and in hippocampus by 1.89- and 1.93-fold, respectively.
  • Spi1 knockdown also increased amyloid plaque burden by 1.76-fold in cortex and 2.59-fold in hippocampus, and increased fibrillar plaque deposition by 1.56- and 1.59-fold, respectively.
  • In 5XFAD mice, Spi1 overexpression decreased insoluble Aβ40 and Aβ42 in cortex by 71.5% and 52.9% in females, and decreased hippocampal Aβ40 and Aβ42 by 29.5% and 22.2%; similar decreases were also observed in males.
  • Spi1 overexpression reduced cortical plaque load by 45.3% and 46.8% and fibrillar plaque burden by 55.6% and 60.9% in female cortex and hippocampus, respectively; it also reduced IBA1- and GFAP-positive cortical area by 46.2% and 54.4% and lowered plaque-associated LAMP1 clusters by 36.3% in cortex and 48.0% in hippocampus.
  • Targeted transcriptomics found 26 DEGs in Spi1-knockdown APP/PS1 cortex and 43 DEGs in Spi1-overexpression 5XFAD cortex; integrative analyses highlighted immune response and complement-related pathways, including TYROBP-centered and microglial phagocytosis pathways.
  • Single-cell RNA-seq of 16,456 filtered cells formed 19 clusters; Spi1 overexpression induced cell-type-specific transcriptional changes, with 16 DEGs in astrocytes, 4 in neurons, and 27 in microglia after a 1.5-fold-change threshold.

## Methods

  • The study used two in vivo mouse models: Spi1+/−;APP/PS1 versus Spi1+/+;APP/PS1 at 4 months, and Spi1Tg/0;5XFAD versus Spi1+/+;5XFAD at 4 months; both sexes were used, but APP/PS1 data were combined across sex while 5XFAD analyses were done separately by sex.
  • Outcomes were measured with biochemical assays for insoluble Aβ, histology/immunofluorescence for plaques, gliosis, and LAMP1-positive dystrophic neurites, plus NanoString AD panels, qRT-PCR validation, in vitro BV-2 fibrillar Aβ uptake assays, and scRNA-seq from 16,456 QC-passed cells.
  • Main analyses included unpaired t-tests, two-way ANOVA with Sidak or Fisher’s LSD post hoc tests, Fisher’s exact test, linear models for NanoString DEGs, enrichment analyses (Enrichr, MetaCore, STRING), and scRNA-seq clustering/annotation with Seurat, scMCA, scWGCNA, and CellChat.

## Limitations

  • The paper states that the inverse relationship between the protective SPI1 rs1057233 allele and lower SPI1 expression in peripheral myeloid cells may not directly translate to brain microglia, and says that a mouse model harboring the SPI1 variant would be needed to test loss- versus gain-of-function directly.
  • The authors note that their mouse and in vitro findings cannot resolve whether lower SPI1 might be protective at later disease stages; this is stated in the discussion.
  • Evident from the text: the study mainly uses 4-month-old mice and focuses on Aβ amyloidosis models, so it does not directly address tau pathology, later disease stages, or human clinical outcomes.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s41467-024-48484-x

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Reducing Spi1 expression increases amyloid plaque deposition in a mouse model of Aβ amyloidosis. The levels of insoluble Aβ40 (a, c) and Aβ42 (b, d) in the guanidine fraction were measured from the cortex (a, b) and hippocampus (c, d) of Spi1+/+;APP/PS1 and Spi1+/−;APP/PS1 mice using Meso Scale Discovery (MSD) Aβ electrochemiluminescence assay. e Representative images of 82E1 (N-terminal Aβ-specific antibody)-positive plaques in brain sections from Spi1+/+;APP/PS1 and Spi1+/−;APP/PS1 mice. Scale bars, 500 μm. Quantification of Aβ plaque load (f, g) and total number of Aβ plaques (h, i) in the cortical area (f, h) and hippocampal area (g, i) of Spi1+/+;APP/PS1 and Spi1+/−;APP/PS1 mice. j Representative images of X-34-positive fibrillar plaques in brain slices from Spi1+/+;APP/PS1 and Spi1+/−;APP/PS1 mice. Scale bars, 500 μm. Quantification of fibrillar plaque load (k, l) and total number of fibrillar plaques (m, n) in the cortical area (k, m) and hippocampal area (i, n) of Spi1+/+;APP/PS1 and Spi1+/−;APP/PS1 mice. All values are mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001 (unpaired, two-tailed t-test; WT, n = 13 (n = 8 males, n = 5 females) for Spi1+/+;APP/PS1; KD, n = 15 (n = 9 males, n = 6 females) for Spi1+/−;APP/PS1. Source data are provided as a Source data file.
Fig. 1 Reducing Spi1 expression increases amyloid plaque deposition in a mouse model of Aβ amyloidosis. The levels of insoluble Aβ40 (a, c) and Aβ42 (b, d) in the guanidine fraction were measured from the cortex (a, b) and hippocampus (c, d) of Spi1+/+;APP/PS1 and Spi1+/−;APP/PS1 mice using Meso Scale Discovery (MSD) Aβ electrochemiluminescence assay. e Representative images of 82E1 (N-terminal Aβ-specific antibody)-positive plaques in brain sections from Spi1+/+;APP/PS1 and Spi1+/−;APP/PS1 mice. Scale bars, 500 μm. Quantification of Aβ plaque load (f, g) and total number of Aβ plaques (h, i) in the cortical area (f, h) and hippocampal area (g, i) of Spi1+/+;APP/PS1 and Spi1+/−;APP/PS1 mice. j Representative images of X-34-positive fibrillar plaques in brain slices from Spi1+/+;APP/PS1 and Spi1+/−;APP/PS1 mice. Scale bars, 500 μm. Quantification of fibrillar plaque load (k, l) and total number of fibrillar plaques (m, n) in the cortical area (k, m) and hippocampal area (i, n) of Spi1+/+;APP/PS1 and Spi1+/−;APP/PS1 mice. All values are mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001 (unpaired, two-tailed t-test; WT, n = 13 (n = 8 males, n = 5 females) for Spi1+/+;APP/PS1; KD, n = 15 (n = 9 males, n = 6 females) for Spi1+/−;APP/PS1. Source data are provided as a Source data file.CC BY · PubMed Central
Fig. 2 Spi1-knockdown increases microgliosis and astrogliosis in mouse model of Aβ amyloidosis. a Representative images of IBA1-positive cells in brain slices from Spi1+/+;APP/PS1 and Spi1+/−;APP/PS1 mice. Scale bars, 500 μm. b Quantification of the IBA1-positive cell load in the cortical area. c Representative images of GFAP-positive cells in brain slices from Spi1+/+;APP/PS1 and Spi1+/−;APP/PS1 mice. Scale bars, 500 μm. d Quantification of the GFAP-positive area in the cortex. All values are mean ± SEM. *p < 0.05 and **p < 0.01 (unpaired, two-tailed t-test; WT, n = 13 (n = 8 males, n = 5 females) for Spi1+/+;APP/PS1; KD, n = 15 (n = 9 males, n = 6 females) for Spi1+/−;APP/PS1). Source data are provided as a Source data file.
Fig. 2 Spi1-knockdown increases microgliosis and astrogliosis in mouse model of Aβ amyloidosis. a Representative images of IBA1-positive cells in brain slices from Spi1+/+;APP/PS1 and Spi1+/−;APP/PS1 mice. Scale bars, 500 μm. b Quantification of the IBA1-positive cell load in the cortical area. c Representative images of GFAP-positive cells in brain slices from Spi1+/+;APP/PS1 and Spi1+/−;APP/PS1 mice. Scale bars, 500 μm. d Quantification of the GFAP-positive area in the cortex. All values are mean ± SEM. *p < 0.05 and **p < 0.01 (unpaired, two-tailed t-test; WT, n = 13 (n = 8 males, n = 5 females) for Spi1+/+;APP/PS1; KD, n = 15 (n = 9 males, n = 6 females) for Spi1+/−;APP/PS1). Source data are provided as a Source data file.CC BY · PubMed Central
Fig. 3 Overexpression of Spi1 reduces plaque deposition in a mouse model of Aβ amyloidosis. The levels of insoluble Aβ40 and Aβ42 were measured in female (a, b) and male (c, d) 5XFAD mice using Meso Scale Discovery (MSD) Aβ assay. Aβ40 and Aβ42 levels in the guanidine fraction from the cortex (a, c) and hippocampus (b, d) of Spi1+/+;5XFAD and Spi1Tg/0;5XFAD mice. All values are mean ± SEM. *p < 0.05 and **p < 0.01 (unpaired, two-tailed t-test; WT, n = 9 for female Spi1+/+;5XFAD, n = 10 for male Spi1+/+;5XFAD; TG, n = 10 for female Spi1Tg/0;5XFAD, n = 11 for male Spi1Tg/0; 5XFAD). e Representative images of 82E1-positive Aβ plaques in brain sections from Spi1+/+;5XFAD and Spi1Tg/0;5XFAD mice. Scale bars, 500 μm. Quantification of Aβ plaque load (f, g) and total number of Aβ plaques (h, i) in the cortical (f, h) and hippocampal (g, i) area of female Spi1+/+;5XFAD and Spi1Tg/0;5XFAD mice. All values are mean ± SEM. *p < 0.05 and **p < 0.01 (unpaired, two-tailed t-test; WT, n = 9 for Spi1+/+;5XFAD; TG, n = 10 for Spi1Tg/0;5XFAD). j Representative images of X-34-positive fibrillar plaques in brain sections from female Spi1+/+;5XFAD and Spi1Tg/0; 5XFAD mice. Scale bars, 500 μm. Quantification of fibrillar plaque load (k, l) and total number of fibrillar plaques (m, n) in the cortical (k, m) and hippocampal (l, n) of female Spi1+/+;5XFAD and Spi1Tg/0;5XFAD mice. All values are mean ± SEM. **p < 0.01 and ***p < 0.001 (unpaired, two-tailed t-test; WT, n = 9 for Spi1+/+;5XFAD; TG, n = 10 for Spi1Tg/0;5XFAD). Source data are provided as a Source data file.
Fig. 3 Overexpression of Spi1 reduces plaque deposition in a mouse model of Aβ amyloidosis. The levels of insoluble Aβ40 and Aβ42 were measured in female (a, b) and male (c, d) 5XFAD mice using Meso Scale Discovery (MSD) Aβ assay. Aβ40 and Aβ42 levels in the guanidine fraction from the cortex (a, c) and hippocampus (b, d) of Spi1+/+;5XFAD and Spi1Tg/0;5XFAD mice. All values are mean ± SEM. *p < 0.05 and **p < 0.01 (unpaired, two-tailed t-test; WT, n = 9 for female Spi1+/+;5XFAD, n = 10 for male Spi1+/+;5XFAD; TG, n = 10 for female Spi1Tg/0;5XFAD, n = 11 for male Spi1Tg/0; 5XFAD). e Representative images of 82E1-positive Aβ plaques in brain sections from Spi1+/+;5XFAD and Spi1Tg/0;5XFAD mice. Scale bars, 500 μm. Quantification of Aβ plaque load (f, g) and total number of Aβ plaques (h, i) in the cortical (f, h) and hippocampal (g, i) area of female Spi1+/+;5XFAD and Spi1Tg/0;5XFAD mice. All values are mean ± SEM. *p < 0.05 and **p < 0.01 (unpaired, two-tailed t-test; WT, n = 9 for Spi1+/+;5XFAD; TG, n = 10 for Spi1Tg/0;5XFAD). j Representative images of X-34-positive fibrillar plaques in brain sections from female Spi1+/+;5XFAD and Spi1Tg/0; 5XFAD mice. Scale bars, 500 μm. Quantification of fibrillar plaque load (k, l) and total number of fibrillar plaques (m, n) in the cortical (k, m) and hippocampal (l, n) of female Spi1+/+;5XFAD and Spi1Tg/0;5XFAD mice. All values are mean ± SEM. **p < 0.01 and ***p < 0.001 (unpaired, two-tailed t-test; WT, n = 9 for Spi1+/+;5XFAD; TG, n = 10 for Spi1Tg/0;5XFAD). Source data are provided as a Source data file.CC BY · PubMed Central
Fig. 4 Spi1-overexpression decreases microgliosis and astrogliosis in a mouse model of Aβ amyloidosis. a Representative images of IBA1-positive cells in brain slices from female Spi1+/+;5XFAD and Spi1Tg/0;5XFAD mice. Scale bars, 500 μm. b Quantification of the IBA1-positive cell load in the cortical area. c Representative images of GFAP-positive cells in brain slices from female Spi1+/+;5XFAD and Spi1Tg/0; 5XFAD mice. Scale bars, 500 μm. d Quantification of the GFAP-positive cell load in the cortical area. All values are mean ± SEM. ***p < 0.001 and ****p < 0.0001 (unpaired, two-tailed t-test; WT, n = 9 for Spi1+/+;5XFAD; TG, n = 11 for Spi1Tg/0; 5XFAD). Source data are provided as a Source data file.
Fig. 4 Spi1-overexpression decreases microgliosis and astrogliosis in a mouse model of Aβ amyloidosis. a Representative images of IBA1-positive cells in brain slices from female Spi1+/+;5XFAD and Spi1Tg/0;5XFAD mice. Scale bars, 500 μm. b Quantification of the IBA1-positive cell load in the cortical area. c Representative images of GFAP-positive cells in brain slices from female Spi1+/+;5XFAD and Spi1Tg/0; 5XFAD mice. Scale bars, 500 μm. d Quantification of the GFAP-positive cell load in the cortical area. All values are mean ± SEM. ***p < 0.001 and ****p < 0.0001 (unpaired, two-tailed t-test; WT, n = 9 for Spi1+/+;5XFAD; TG, n = 11 for Spi1Tg/0; 5XFAD). Source data are provided as a Source data file.CC BY · PubMed Central
Fig. 5 Analyses of transcriptomic changes induced by Spi1-knockdown and Spi1-overexpression in Aβ amyloidosis mouse models. a–c Differentially expressed genes (DEGs) in cortex of Spi1+/−;APP/PS1 versus Spi1+/+;APP/PS1 mice identified by NanoString analysis and their pathway enrichment analyses. a Volcano plot showing DEGs in Spi1+/−;APP/PS1 mice compared to Spi1+/+;APP/PS1 mice (n = 3 males per genotype). The red dots represent significantly upregulated genes, and blue dots represent significantly downregulated genes in Spi1+/−;APP/PS1 versus Spi1+/+;APP/PS1 mice (p < 0.05, indicated as a horizontal dash line; fold change > ±1.3, indicated as a vertical dash line). The volcano plot shows statistical significance as the -log10 P-value (y-axis) and the log2 Fold Change (log2FC, x-axis). Pathway enrichment analysis with the functional annotation of DEGs was performed using EnrichR (b) and MetaCore (c) software. d, qPCR analysis of several DEGs in cortex between Spi1+/−;APP/PS1 mice and Spi1+/+;APP/PS1 mice. All values are mean ± SEM. *p < 0.05, **p < 0.01, and ***p < 0.001 (unpaired, two-tailed t-test; WT, n = 8 (n = 4 males, n = 4 females) for Spi1+/+;APP/PS1; KD, n = 8 (n = 4 males, n = 4 females) for Spi1+/−;APP/PS1). e–h DEGs in cortex of Spi1Tg/0;5XFAD versus Spi1+/+; 5XFAD mice identified by NanoString analysis and pathway enrichment analyses. e Volcano plot showing DEGs in Spi1Tg/0;5XFAD versus Spi1+/+;5XFAD mice (n = 3 females per genotype). The volcano plot shows statistical significance as the -log10 P-value (y-axis) and the log2FC (x-axis). The red and blue dots represent significantly upregulated and downregulated genes, respectively, in Spi1Tg/0;5XFAD versus Spi1+/+;5XFAD mice (p < 0.05, indicated as a horizontal dash line; fold change > ±1.3, indicated as a vertical dash line). Pathway enrichment analysis of DEGs identified using EnrichR (f) and MetaCore (g) software. h qPCR analysis of several DEGs in cortex between females Spi1Tg/0;5XFAD mice and Spi1+/+;5XFAD mice. All values are mean ± SEM. *p < 0.05, **p < 0.01, and ****p < 0.0001 (unpaired, two-tailed t-test; WT, n = 8 for Spi1+/+;5XFAD; TG, n = 8 for Spi1Tg/0;5XFAD). P-values of b and f were calculated using two-tailed Fisher’s exact test, while those for c and g were determined using Metacore algorithms, both with a threshold of significant enrichment as p < 0.05 (shown as a vertical dash line for b, c, f, and g). Source data are provided as a Source data file.
Fig. 5 Analyses of transcriptomic changes induced by Spi1-knockdown and Spi1-overexpression in Aβ amyloidosis mouse models. a–c Differentially expressed genes (DEGs) in cortex of Spi1+/−;APP/PS1 versus Spi1+/+;APP/PS1 mice identified by NanoString analysis and their pathway enrichment analyses. a Volcano plot showing DEGs in Spi1+/−;APP/PS1 mice compared to Spi1+/+;APP/PS1 mice (n = 3 males per genotype). The red dots represent significantly upregulated genes, and blue dots represent significantly downregulated genes in Spi1+/−;APP/PS1 versus Spi1+/+;APP/PS1 mice (p < 0.05, indicated as a horizontal dash line; fold change > ±1.3, indicated as a vertical dash line). The volcano plot shows statistical significance as the -log10 P-value (y-axis) and the log2 Fold Change (log2FC, x-axis). Pathway enrichment analysis with the functional annotation of DEGs was performed using EnrichR (b) and MetaCore (c) software. d, qPCR analysis of several DEGs in cortex between Spi1+/−;APP/PS1 mice and Spi1+/+;APP/PS1 mice. All values are mean ± SEM. *p < 0.05, **p < 0.01, and ***p < 0.001 (unpaired, two-tailed t-test; WT, n = 8 (n = 4 males, n = 4 females) for Spi1+/+;APP/PS1; KD, n = 8 (n = 4 males, n = 4 females) for Spi1+/−;APP/PS1). e–h DEGs in cortex of Spi1Tg/0;5XFAD versus Spi1+/+; 5XFAD mice identified by NanoString analysis and pathway enrichment analyses. e Volcano plot showing DEGs in Spi1Tg/0;5XFAD versus Spi1+/+;5XFAD mice (n = 3 females per genotype). The volcano plot shows statistical significance as the -log10 P-value (y-axis) and the log2FC (x-axis). The red and blue dots represent significantly upregulated and downregulated genes, respectively, in Spi1Tg/0;5XFAD versus Spi1+/+;5XFAD mice (p < 0.05, indicated as a horizontal dash line; fold change > ±1.3, indicated as a vertical dash line). Pathway enrichment analysis of DEGs identified using EnrichR (f) and MetaCore (g) software. h qPCR analysis of several DEGs in cortex between females Spi1Tg/0;5XFAD mice and Spi1+/+;5XFAD mice. All values are mean ± SEM. *p < 0.05, **p < 0.01, and ****p < 0.0001 (unpaired, two-tailed t-test; WT, n = 8 for Spi1+/+;5XFAD; TG, n = 8 for Spi1Tg/0;5XFAD). P-values of b and f were calculated using two-tailed Fisher’s exact test, while those for c and g were determined using Metacore algorithms, both with a threshold of significant enrichment as p < 0.05 (shown as a vertical dash line for b, c, f, and g). Source data are provided as a Source data file.CC BY · PubMed Central
Fig. 6 Integrative analysis of Spi1-mediated transcriptomic alterations. DEGs in Spi1+/−;APP/PS1 (KD) versus Spi1+/+;APP/PS1 (WT) and Spi1Tg/0;5XFAD (TG) versus Spi1+/+;5XFAD (WT) mice were analyzed with a linear regression model for genotypes. a Workflow for LIMMA analysis. Transcription factor enrichment analysis (b) and Pathway enrichment analysis (c) with combined DEGs were performed using the MetaCore software. P-values of b and c were calculated using Metacore algorithms with a threshold of significant enrichment as p < 0.05 (shown as a vertical dash line for b and c). d All DEGs were summarized in a Venn diagram, which identified six shared DEGs across Spi1+/−;APP/PS1 versus Spi1+/+;APP/PS1 mice and Spi1Tg/0;5XFAD versus Spi1+/+;5XFAD mice. e Relative expression levels of six shared DEGs. Quantification data were expressed as log2FC of expression relative to each control group. All values are mean ± SEM (n = 3 per group). f A protein-protein interaction network was generated using the STRING database for the combined DEGs (63 genes) and Spi1. The data showed interactions with Spi1 and among all DEGs. Wider lines represent stronger evidence of interactions. g Integrative pathmap analysis was performed using both sets of DEGs using MetaCore. Up-regulated genes in our dataset are shown with red circles, down-regulated genes are shown with blue circles, and the mixed-signal gene is shown with a red-blue mixed circle in the pathmap. Green arrows between nodes represent activation, while gray arrows represent interaction with no specific direction of effect. DEGs shown are involved in the immune response and complement system. Source data are provided as a Source data file.
Fig. 6 Integrative analysis of Spi1-mediated transcriptomic alterations. DEGs in Spi1+/−;APP/PS1 (KD) versus Spi1+/+;APP/PS1 (WT) and Spi1Tg/0;5XFAD (TG) versus Spi1+/+;5XFAD (WT) mice were analyzed with a linear regression model for genotypes. a Workflow for LIMMA analysis. Transcription factor enrichment analysis (b) and Pathway enrichment analysis (c) with combined DEGs were performed using the MetaCore software. P-values of b and c were calculated using Metacore algorithms with a threshold of significant enrichment as p < 0.05 (shown as a vertical dash line for b and c). d All DEGs were summarized in a Venn diagram, which identified six shared DEGs across Spi1+/−;APP/PS1 versus Spi1+/+;APP/PS1 mice and Spi1Tg/0;5XFAD versus Spi1+/+;5XFAD mice. e Relative expression levels of six shared DEGs. Quantification data were expressed as log2FC of expression relative to each control group. All values are mean ± SEM (n = 3 per group). f A protein-protein interaction network was generated using the STRING database for the combined DEGs (63 genes) and Spi1. The data showed interactions with Spi1 and among all DEGs. Wider lines represent stronger evidence of interactions. g Integrative pathmap analysis was performed using both sets of DEGs using MetaCore. Up-regulated genes in our dataset are shown with red circles, down-regulated genes are shown with blue circles, and the mixed-signal gene is shown with a red-blue mixed circle in the pathmap. Green arrows between nodes represent activation, while gray arrows represent interaction with no specific direction of effect. DEGs shown are involved in the immune response and complement system. Source data are provided as a Source data file.CC BY · PubMed Central
Fig. 7 Spi1-knockdown reduces microglial response to plaques and Aβ uptake, whereas Spi1-overexpression increases them. Representative images of colocalization between IBA1-positive microglia and X-34-positive fibrillar plaque in brain slices from Spi1+/+;APP/PS1 and Spi1+/−;APP/PS1 mice (a) or from Spi1+/+;5XFAD and Spi1Tg/0;5XFAD mice (c). Scale bars, 20 μm. b, d Quantification of the IBA1-positive cell coverage area on the fibrillar plaque. Within each box, horizontal lines denote median values; boxes extend from the 25th to the 75th percentile of each group’s distribution of values. The whiskers are shown from min to max, showing all points. ****p < 0.0001 (unpaired, two-tailed t-test). For a and b, WT, n = 13 (n = 8 males, n = 5 females) for Spi1+/+;APP/PS1; KD, n = 15 (n = 9 males, n = 6 females) for Spi1+/−;APP/PS1. For c-d, WT, n = 9 females for Spi1+/+;5XFAD; TG, n = 10 females for Spi1Tg/0; 5XFAD). e, f BV-2 microglial cells were transfected with a Spi1 siRNA or Spi1 plasmid to knockdown or overexpression of Spi1, respectively. Twenty-four hours post-transfection, cells were incubated with 100 nM of Aβ1-42 conjugated with pHrodo Red dye for 48 h. Time-lapse of Aβ uptake level of Spi1-knockdown (e) or -overexpression (f) was compared to each negative control (scrambled siRNA or Empty vector, respectively) under Aβ treatment. The Aβ uptake level in the cells was evaluated using the relative fluorescence unit (RFU) of pHrodo Red emission. All values are mean ± SD. *p < 0.05, **p < 0.01, and ****p < 0.0001 (two-way ANOVA, Sidak’s multiple comparisons test; n = 5 per group). Source data are provided as a Source data file.
Fig. 7 Spi1-knockdown reduces microglial response to plaques and Aβ uptake, whereas Spi1-overexpression increases them. Representative images of colocalization between IBA1-positive microglia and X-34-positive fibrillar plaque in brain slices from Spi1+/+;APP/PS1 and Spi1+/−;APP/PS1 mice (a) or from Spi1+/+;5XFAD and Spi1Tg/0;5XFAD mice (c). Scale bars, 20 μm. b, d Quantification of the IBA1-positive cell coverage area on the fibrillar plaque. Within each box, horizontal lines denote median values; boxes extend from the 25th to the 75th percentile of each group’s distribution of values. The whiskers are shown from min to max, showing all points. ****p < 0.0001 (unpaired, two-tailed t-test). For a and b, WT, n = 13 (n = 8 males, n = 5 females) for Spi1+/+;APP/PS1; KD, n = 15 (n = 9 males, n = 6 females) for Spi1+/−;APP/PS1. For c-d, WT, n = 9 females for Spi1+/+;5XFAD; TG, n = 10 females for Spi1Tg/0; 5XFAD). e, f BV-2 microglial cells were transfected with a Spi1 siRNA or Spi1 plasmid to knockdown or overexpression of Spi1, respectively. Twenty-four hours post-transfection, cells were incubated with 100 nM of Aβ1-42 conjugated with pHrodo Red dye for 48 h. Time-lapse of Aβ uptake level of Spi1-knockdown (e) or -overexpression (f) was compared to each negative control (scrambled siRNA or Empty vector, respectively) under Aβ treatment. The Aβ uptake level in the cells was evaluated using the relative fluorescence unit (RFU) of pHrodo Red emission. All values are mean ± SD. *p < 0.05, **p < 0.01, and ****p < 0.0001 (two-way ANOVA, Sidak’s multiple comparisons test; n = 5 per group). Source data are provided as a Source data file.CC BY · PubMed Central
Fig. 8 Spi1-overexpression decreases axonal dystrophic neurites in a mouse model of Aβ amyloidosis. a Representative images of brain sections from Spi1+/+; 5XFAD and Spi1Tg/0;5XFAD mice co-stained with anti-LAMP1 and -Aβ (82E1) antibodies. Scale bars, 500 μm. Quantification of the LAMP1-positive load (b, c) and number of LAMP1-positive with 82E1-positive plaques (d, e) in the cortical (b, d) and hippocampal (c, e) area of female Spi1+/+;5XFAD and Spi1Tg/0;5XFAD mice. All values are mean ± SEM. *p < 0.05, **p < 0.01, and ***p < 0.001 (unpaired, two-tailed t-test; WT, n = 9 for Spi1+/+;5XFAD; TG, n = 11 for Spi1Tg/0;5XFAD). Source data are provided as a Source data file.
Fig. 8 Spi1-overexpression decreases axonal dystrophic neurites in a mouse model of Aβ amyloidosis. a Representative images of brain sections from Spi1+/+; 5XFAD and Spi1Tg/0;5XFAD mice co-stained with anti-LAMP1 and -Aβ (82E1) antibodies. Scale bars, 500 μm. Quantification of the LAMP1-positive load (b, c) and number of LAMP1-positive with 82E1-positive plaques (d, e) in the cortical (b, d) and hippocampal (c, e) area of female Spi1+/+;5XFAD and Spi1Tg/0;5XFAD mice. All values are mean ± SEM. *p < 0.05, **p < 0.01, and ***p < 0.001 (unpaired, two-tailed t-test; WT, n = 9 for Spi1+/+;5XFAD; TG, n = 11 for Spi1Tg/0;5XFAD). Source data are provided as a Source data file.CC BY · PubMed Central
Fig. 9 Analyses of transcriptomic changes and cell-type specific gene expression signatures induced by Spi1-overexpression in an Aβ amyloidosis mouse model. a–f scRNA-seq analysis identified 19 clusters of cell types in 4-month-old Spi1+/+;5XFAD and Spi1Tg/0;5XFAD mouse brains. a UMAP plots showing the 19 annotated cell type clusters for each genotype. The clustering dendrogram shows cluster relatedness. b Heatmap of KEGG terms generated from microglial cluster DEGs. P-values of KEGG term enrichment were calculated in Gprofiler2 using a two-tailed Fisher’s exact test with significant enrichment as p < 0.05. Darker colors represent greater term enrichment in each gene list. c Sixteen co-expressed gene modules were identified using Single Cell Weighted Gene Network Correlation Analysis (scWGCNA). d UMAP plot showing the enrichment of 16 co-expressed gene modules across different clusters. e Chord Plot showing that microglial cluster 4 signals to other microglial clusters. The color of each outer band represents the identity of each cell cluster. Inner bands for the cluster 4 microglia represent the identity of each cell cluster that expresses a particular receptor or an interacting protein for the ligand expressed in the cluster 4 microglia. The color of these inner bands is based on the cell cluster targeted by the cluster 4 microglia. f CCL Signaling Chord Plot showing CCL pathway signaling between microglial clusters. The color of the outer bands and chords represents the identity of the cell cluster (M1-11 = microglia, A1-2 = astrocytes, En = endothelial cells, Er = erythrocytes, Ma = macrophages, N1 = neurons, O = oligodendrocytes, and T = T-cells). The color of the inner bands is based on the identity of the cell cluster targeted. Source data are provided as a Source data file.
Fig. 9 Analyses of transcriptomic changes and cell-type specific gene expression signatures induced by Spi1-overexpression in an Aβ amyloidosis mouse model. a–f scRNA-seq analysis identified 19 clusters of cell types in 4-month-old Spi1+/+;5XFAD and Spi1Tg/0;5XFAD mouse brains. a UMAP plots showing the 19 annotated cell type clusters for each genotype. The clustering dendrogram shows cluster relatedness. b Heatmap of KEGG terms generated from microglial cluster DEGs. P-values of KEGG term enrichment were calculated in Gprofiler2 using a two-tailed Fisher’s exact test with significant enrichment as p < 0.05. Darker colors represent greater term enrichment in each gene list. c Sixteen co-expressed gene modules were identified using Single Cell Weighted Gene Network Correlation Analysis (scWGCNA). d UMAP plot showing the enrichment of 16 co-expressed gene modules across different clusters. e Chord Plot showing that microglial cluster 4 signals to other microglial clusters. The color of each outer band represents the identity of each cell cluster. Inner bands for the cluster 4 microglia represent the identity of each cell cluster that expresses a particular receptor or an interacting protein for the ligand expressed in the cluster 4 microglia. The color of these inner bands is based on the cell cluster targeted by the cluster 4 microglia. f CCL Signaling Chord Plot showing CCL pathway signaling between microglial clusters. The color of the outer bands and chords represents the identity of the cell cluster (M1-11 = microglia, A1-2 = astrocytes, En = endothelial cells, Er = erythrocytes, Ma = macrophages, N1 = neurons, O = oligodendrocytes, and T = T-cells). The color of the inner bands is based on the identity of the cell cluster targeted. Source data are provided as a Source data file.CC BY · PubMed Central

Verification

Claims the paper makes

31 Valid · 3 Not valid · 19 Not checked · 106 Own results and interpretations

105 more claims · 14 with their cited sources checked

Create a free account to see all 159 claims and to verify the 3 references still open.

See all claims — free account
  • Probably not a substantial claim. 28
  • It may state two separate claims as one. 26
  • The quote only partly states this claim. 3

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

17 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 53 references

Cited by

See all 32

Metadata

Authors
Kim, B., Dabin, L. C., Tate, M. D., Karahan, H., Sharify, A. D., Acri, D. J., Al-Amin, M. M., Philtjens, S., Smith, D. C., Wijeratne, H. R. S., Park, J. H., Jucker, M., & Kim, J.
Affiliations
  • Indiana University Indianapolis (US)
  • Indiana University School of Medicine (US)
  • Indiana University Bloomington (US)
  • German Center for Neurodegenerative Diseases (DE)
Corresponding author
Kim, Jungsu
Venue
Nature Communications
Published
2024-05-11
Volume
15
Issue
1
Pages
3996-3996
ISSN
2041-1723 (ISSN-L)
OpenAlex
W4396826754
Cited by
28
References
53
Citations by year
2026: 7 · 2025: 18 · 2024: 3
FWCI
7.90
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • IUScholarWorks (Indiana University) (submittedVersion, cc-by)
  • DZNE Pub (submittedVersion, cc-by)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • U.S. Department of Health & Human Services | NIH | National Institute on Aging (R01AG077829, R01AG071281, R21AG072738, RF1AG074543)
  • Alzheimer&apos;s Association (AARF-21-852175)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
PU.1, Alzheimer's disease, amyloid-beta, amyloid plaques, gliosis, dystrophic neurites, transcriptome remodeling, transcriptional reprogramming, complement system, immune response, druggable targets, mouse model
MeSH terms
Proto-Oncogene Protein Spi-1, Alzheimer Disease, Amyloidosis, Animals, Disease Models, Animal, Male, Mice, Inbred C57BL, Mice, Transgenic, Phenotype, Proto-Oncogene Proteins, Trans-Activators, Amyloid beta-Peptides, Gene Expression Profiling, Mice, Gene Knockdown Techniques, Plaque, Amyloid, Transcriptome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of SPI1-mediated transcriptome remodeling on Alzheimer's disease-related phenotypes in mouse models of Aβ amyloidosis. https://app.cochat.ai/papers/10.1038/s41467-024-48484-x
The paper
Kim, B., Dabin, L. C., Tate, M. D., Karahan, H., Sharify, A. D., Acri, D. J., Al-Amin, M. M., Philtjens, S., Smith, D. C., Wijeratne, H. R. S., Park, J. H., Jucker, M., & Kim, J. (2024). Effects of SPI1-mediated transcriptome remodeling on Alzheimer's disease-related phenotypes in mouse models of Aβ amyloidosis. Nature Communications. https://doi.org/10.1038/s41467-024-48484-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.